Arielis

At Eli Lilly, tears, heartbreak and renewed determination

At Eli Lilly, tears, heartbreak and renewed determination | Indianapolis Business Journal | December 03, 2016
Health
Source: Indianapolis Business Journal
December 03, 2016
Eli Lilly and Co. employees knew the Alzheimer's treatment solanezumab was not a sure bet. But that didn't make the pain any less acute after the company announced the drug had failed to demonstrate effectiveness during a 2,100-patient Phase 3 clinical trial.

Read Full Story
Popular Articles